The median approval time for all new drug and biologic product applications dropped from a high of over 20 months in Fiscal Year (FY) 1994 to just over 11 months in FY 1999.
The median approval time for priority drug and biologic product applications dropped from over 13 months in FY 1993 to 6 months in FY 1999.